Track papers across labs, topics, and trends.
Search papers, labs, and topics across Lattice.
This paper explores using machine learning to objectively evaluate the severity of PTSD by analyzing physiological signals. They trained a fear-response model on an arachnophobia dataset and then extracted predictive features from HR and GSR data collected from military personnel during an immersive simulation. The resulting model achieved 86% accuracy in classifying PTSD status and estimated PTSD severity with a 17% mean absolute percentage error.
Objective PTSD severity assessment is possible with 86% accuracy by transferring learned fear responses from arachnophobia data to physiological signals of individuals experiencing simulated trauma.
Posttraumatic stress disorder (PTSD) is a prevalent and debilitating mental health condition with significant personal and societal impacts. Current clinical assessments of PTSD often rely on subjective evaluations, which can be time-consuming, costly, and prone to human bias. This study proposes a machine learning (ML) approach based on multivariate kernel density estimation (MKDE) technique for the objective evaluation of PTSD severity. We collected heart rate (HR) and galvanic skin response (GSR) signals as well as PTSD Checklist - Military Version (PCL-M) labels from 21 participants during an immersive simulation. A fear-response model was trained on a public arachnophobia dataset, and predictive features of PTSD were extracted from the fear-response curves estimated on the military dataset. The model achieved an accuracy of 86\% in classifying PTSD status, effectively distinguishing participants with and without PTSD (PCL-M threshold of 36). The average mean absolute error (MAE) of the models is 5.6, and it estimated a clinical PTSD severity scale with a mean absolute percentage error of 17\%. Our algorithm demonstrates promising potential for enhancing estimation of PTSD severity and followup by offering an objective and low-effort evaluation approach using physiology. These findings suggest clinical utility in both screening and follow-up settings.